Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage. Reply.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- August 22, 2024
has subject area
- 11 Medical and Health Sciences (FoR)
- Anticoagulation Reversal (MeSH)
- Cerebral Hemorrhage (MeSH)
- Clinical Trials, Phase IV as Topic (MeSH)
- Factor Xa (MeSH)
- Factor Xa Inhibitors (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Multicenter Studies as Topic (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Recombinant Proteins (MeSH)
- Research Design (MeSH)
- Rivaroxaban (MeSH)
published in
- New England Journal of Medicine Journal